ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - water for injections - ממס לשימוש במתן פארנטרלי - water for injections 100 % - other i.v. solution additives - for the preparation of parenterals, vehicle solution for supplementary medication, as a diluent or as water for injection

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - water for injections - ממס לשימוש במתן פארנטרלי - water for injections 100 ml - other i.v. solution additives - for the preparation of parenterals, vehicle solution for supplementary medication, as a diluent or as water for injection

ישראל - עברית - Ministry of Health

medic trim healthcare ltd - aminophylline as dihydrate 250 mg / 10 ml - solution for injection - aminophylline - for symptomatic relief or prevention of bronchial asthma and for treatment of reversible bronchospasm associated with chronic bronchitis and emphysema.

ישראל - עברית - Ministry of Health

abic veterinary products ltd - ferrous as dextran 200 mg/ml - solution for injection - for prevention and treatment of anemia caused by iron deficiency in calves and piglets.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - palonosetron as hydrochloride 0.05 mg / 1 ml - solution for injection - palonosetron - prevention of chemotherapy - induced nausea and vomiting (cinv).

ישראל - עברית - Ministry of Health

romat ltd - ivermectin 10.0 mg/ml - solution for injection - prevention and treatment of gastro-intestinal nematodes, lungworms, eyeworm, myiasis ( warble, screw worm) mites, lice, nasal worm, and as aid in control of ticks, in sheep and pigs.

ישראל - עברית - Ministry of Health

comex ltd - water for injections 100 % - solvent for parenteral use - for use as a sterile solvent for the preparation of medicine intended for parenteral administration where water is a component of the preparation and for reconstituting or diluting medicines for parenteral administration immediatly after use.

ישראל - עברית - Ministry of Health

j-c health care ltd - erythropoietin human recombinant - תמיסה להזרקה - erythropoietin human recombinant 40000 iu/ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - medetomidine hydrochloride 1 mg/ml - solution for injection - dogs:for restraint, sedation and analgesia associated with clinical examinations and procedures, minor surgery and pre-anaesthesia.as a premedicant before thiopentone, halothane general anaesthesia and as a premedicant before general anaesthesia with propofol.cats:for restraint and sedation.in combination with ketamine for induction of general anaesthesia prior to surgical procedures.

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - atosiban - solution for injection - atosiban 7.5 mg/ml - atosiban - atosiban - atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for iparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.